176 related articles for article (PubMed ID: 20363507)
1. Natural history of radiation papillopathy after proton beam irradiation of parapapillary melanoma.
Kim IK; Lane AM; Egan KM; Munzenrider J; Gragoudas ES
Ophthalmology; 2010 Aug; 117(8):1617-22. PubMed ID: 20363507
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for radiation maculopathy and papillopathy after intraocular irradiation.
Gragoudas ES; Li W; Lane AM; Munzenrider J; Egan KM
Ophthalmology; 1999 Aug; 106(8):1571-7; discussion 1577-8. PubMed ID: 10442906
[TBL] [Abstract][Full Text] [Related]
3. Proton beam therapy of parapapillary choroidal melanoma.
Riechardt AI; Cordini D; Willerding GD; Georgieva I; Weber A; Seibel I; Lakotka N; Bechrakis NE; Foerster MH; Moser L; Joussen AM
Am J Ophthalmol; 2014 Jun; 157(6):1258-65. PubMed ID: 24548873
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal triamcinolone acetonide for acute radiation papillopathy.
Shields CL; Demirci H; Marr BP; Mashayekhi A; Dai VV; Materin MA; Shields JA
Retina; 2006; 26(5):537-44. PubMed ID: 16770260
[TBL] [Abstract][Full Text] [Related]
5. Treatment of metastatic tumors of the choroid with proton beam irradiation.
Tsina EK; Lane AM; Zacks DN; Munzenrider JE; Collier JM; Gragoudas ES
Ophthalmology; 2005 Feb; 112(2):337-43. PubMed ID: 15691572
[TBL] [Abstract][Full Text] [Related]
6. A five-year study of slotted eye plaque radiation therapy for choroidal melanoma: near, touching, or surrounding the optic nerve.
Finger PT; Chin KJ; Tena LB
Ophthalmology; 2012 Feb; 119(2):415-22. PubMed ID: 22133796
[TBL] [Abstract][Full Text] [Related]
7. Visual-field deficits associated with proton beam irradiation for parapapillary choroidal melanoma.
Park SS; Walsh SM; Gragoudas ES
Ophthalmology; 1996 Jan; 103(1):110-6. PubMed ID: 8628541
[TBL] [Abstract][Full Text] [Related]
8. Visual Outcomes after Proton Beam Irradiation for Choroidal Melanomas Involving the Fovea.
Patel AV; Lane AM; Morrison MA; Trofimov AV; Shih HA; Gragoudas ES; Kim IK
Ophthalmology; 2016 Feb; 123(2):369-377. PubMed ID: 26545316
[TBL] [Abstract][Full Text] [Related]
9. Proliferative radiation retinopathy after plaque radiotherapy for uveal melanoma.
Bianciotto C; Shields CL; Pirondini C; Mashayekhi A; Furuta M; Shields JA
Ophthalmology; 2010 May; 117(5):1005-12. PubMed ID: 20079924
[TBL] [Abstract][Full Text] [Related]
10. [Radiation optic neuropathy after the brachytherapy of the uveal melanoma].
Szuścik I; Romanowska-Dixon B; Markiewicz A; Pogrzebielski A; Jakubowska B
Klin Oczna; 2006; 108(7-9):278-80. PubMed ID: 17290823
[TBL] [Abstract][Full Text] [Related]
11. Proton irradiation for peripapillary and parapapillary melanomas.
Lane AM; Kim IK; Gragoudas ES
Arch Ophthalmol; 2011 Sep; 129(9):1127-30. PubMed ID: 21911661
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up after uveal melanoma charged particle therapy.
Char DH; Kroll SM; Castro J
Trans Am Ophthalmol Soc; 1997; 95():171-87; discussion 187-91. PubMed ID: 9440169
[TBL] [Abstract][Full Text] [Related]
13. [Retrospective analysis of ruthenium-106 brachytherapy for small and medium-sized malignant melanoma of the posterior choroid].
Stoffelns BM; Kutzner J; Jochem T
Klin Monbl Augenheilkd; 2002 Apr; 219(4):216-20. PubMed ID: 12022004
[TBL] [Abstract][Full Text] [Related]
14. Tumor-related lipid exudation after plaque radiotherapy of choroidal melanoma: the role of Bruch's membrane rupture.
Mashayekhi A; Tuncer S; Shields CL; Shields JA
Ophthalmology; 2010 May; 117(5):1013-23. PubMed ID: 20097428
[TBL] [Abstract][Full Text] [Related]
15. Plaque radiotherapy for juxtapapillary choroidal melanoma overhanging the optic disc in 141 consecutive patients.
Sagoo MS; Shields CL; Mashayekhi A; Freire J; Emrich J; Reiff J; Komarnicky L; Shields JA
Arch Ophthalmol; 2008 Nov; 126(11):1515-22. PubMed ID: 19001218
[TBL] [Abstract][Full Text] [Related]
16. Plaque radiotherapy for juxtapapillary choroidal melanoma: treatment complications and visual outcomes in 650 consecutive cases.
Sagoo MS; Shields CL; Emrich J; Mashayekhi A; Komarnicky L; Shields JA
JAMA Ophthalmol; 2014 Jun; 132(6):697-702. PubMed ID: 24652552
[TBL] [Abstract][Full Text] [Related]
17. Estimates of ocular and visual retention following treatment of extra-large uveal melanomas by proton beam radiotherapy.
Conway RM; Poothullil AM; Daftari IK; Weinberg V; Chung JE; O'Brien JM
Arch Ophthalmol; 2006 Jun; 124(6):838-43. PubMed ID: 16769837
[TBL] [Abstract][Full Text] [Related]
18. Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27.
Collaborative Ocular Melanoma Study Group
Ophthalmology; 2007 Jul; 114(7):1363-71. PubMed ID: 17337065
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric and late radiation toxicity comparison between iodine-125 brachytherapy and stereotactic radiation therapy for juxtapapillary choroidal melanoma.
Krema H; Heydarian M; Beiki-Ardakani A; Weisbrod D; Xu W; Laperriere NJ; Sahgal A
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):510-5. PubMed ID: 23507292
[TBL] [Abstract][Full Text] [Related]
20. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY DETECTS SUBCLINICAL RADIAL PERIPAPILLARY CAPILLARY DENSITY REDUCTION AFTER PLAQUE RADIOTHERAPY FOR CHOROIDAL MELANOMA.
Chien JL; Sioufi K; Ferenczy SR; Say EAT; Shields CL
Retina; 2020 Sep; 40(9):1774-1782. PubMed ID: 31652197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
